US6 gene deletion in Herpes simplex virus type 2 enhances dendritic cell function and T cell activation

Angello Retamal-Díaz, Kayla A. Weiss, Eduardo I. Tognarelli, Mariela Freire, Susan M. Bueno, Betsy Herold, William R. Jacobs, Pablo A. González

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Herpes simplex virus (HSV) type 1 (HSV-1) and type 2 (HSV-2) produce lifelong infections that are associated with frequent asymptomatic or clinically apparent reactivation. Importantly, HSV express multiple virulence factors that negatively modulate innate and adaptive immune components. Notably, HSV interfere with dendritic cell (DC) viability and function, likely hindering the capacity of the host to mount effective immunity against these viruses. Recently, an HSV-2 virus that was deleted in glycoprotein D was engineered (designated ΔgD-2). The virus is propagated on a complementing cell line that expresses HSV-1 gD, which permits a single round of viral replication. ΔgD-2 is safe, immunogenic, and provided complete protection against vaginal or skin challenges with HSV-1 and HSV-2 in murine models. Here, we sought to assess the interaction of ΔgD-2 with DCs and found that, in contrast to wild-type (WT) virus which induces DC apoptosis, ΔgD-2 promoted their migration and capacity to activate naïve CD8+ and CD4+ T cells in vitro and in vivo. Furthermore, DCs exposed to the WT and ΔgD-2 virus experienced different unfolded protein responses. Mice primed with DCs infected with ΔgD-2 in vitro displayed significantly reduced infection and pathology after genital challenge with virulent HSV-2 compared to non-primed mice, suggesting that DCs play a role in the immune response to the vaccine strain.

Original languageEnglish (US)
Article number1523
JournalFrontiers in Immunology
Volume8
Issue numberNOV
DOIs
StatePublished - Nov 10 2017

Fingerprint

Human Herpesvirus 2
Gene Deletion
Dendritic Cells
Viruses
T-Lymphocytes
Human Herpesvirus 1
Simplexvirus
Unfolded Protein Response
Virulence Factors
Infection
Immunity
Cell Survival
Glycoproteins
Vaccines
Apoptosis
Pathology
Cell Line
Skin

Keywords

  • Adaptive immunity
  • Apoptosis
  • Dendritic cells
  • Glycoprotein D
  • HSV type 2
  • Migration
  • Unfolded protein response

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Retamal-Díaz, A., Weiss, K. A., Tognarelli, E. I., Freire, M., Bueno, S. M., Herold, B., ... González, P. A. (2017). US6 gene deletion in Herpes simplex virus type 2 enhances dendritic cell function and T cell activation. Frontiers in Immunology, 8(NOV), [1523]. https://doi.org/10.3389/fimmu.2017.01523

US6 gene deletion in Herpes simplex virus type 2 enhances dendritic cell function and T cell activation. / Retamal-Díaz, Angello; Weiss, Kayla A.; Tognarelli, Eduardo I.; Freire, Mariela; Bueno, Susan M.; Herold, Betsy; Jacobs, William R.; González, Pablo A.

In: Frontiers in Immunology, Vol. 8, No. NOV, 1523, 10.11.2017.

Research output: Contribution to journalArticle

Retamal-Díaz, A, Weiss, KA, Tognarelli, EI, Freire, M, Bueno, SM, Herold, B, Jacobs, WR & González, PA 2017, 'US6 gene deletion in Herpes simplex virus type 2 enhances dendritic cell function and T cell activation', Frontiers in Immunology, vol. 8, no. NOV, 1523. https://doi.org/10.3389/fimmu.2017.01523
Retamal-Díaz, Angello ; Weiss, Kayla A. ; Tognarelli, Eduardo I. ; Freire, Mariela ; Bueno, Susan M. ; Herold, Betsy ; Jacobs, William R. ; González, Pablo A. / US6 gene deletion in Herpes simplex virus type 2 enhances dendritic cell function and T cell activation. In: Frontiers in Immunology. 2017 ; Vol. 8, No. NOV.
@article{05e634d0e8f145f1a2d5f1a50162e668,
title = "US6 gene deletion in Herpes simplex virus type 2 enhances dendritic cell function and T cell activation",
abstract = "Herpes simplex virus (HSV) type 1 (HSV-1) and type 2 (HSV-2) produce lifelong infections that are associated with frequent asymptomatic or clinically apparent reactivation. Importantly, HSV express multiple virulence factors that negatively modulate innate and adaptive immune components. Notably, HSV interfere with dendritic cell (DC) viability and function, likely hindering the capacity of the host to mount effective immunity against these viruses. Recently, an HSV-2 virus that was deleted in glycoprotein D was engineered (designated ΔgD-2). The virus is propagated on a complementing cell line that expresses HSV-1 gD, which permits a single round of viral replication. ΔgD-2 is safe, immunogenic, and provided complete protection against vaginal or skin challenges with HSV-1 and HSV-2 in murine models. Here, we sought to assess the interaction of ΔgD-2 with DCs and found that, in contrast to wild-type (WT) virus which induces DC apoptosis, ΔgD-2 promoted their migration and capacity to activate na{\"i}ve CD8+ and CD4+ T cells in vitro and in vivo. Furthermore, DCs exposed to the WT and ΔgD-2 virus experienced different unfolded protein responses. Mice primed with DCs infected with ΔgD-2 in vitro displayed significantly reduced infection and pathology after genital challenge with virulent HSV-2 compared to non-primed mice, suggesting that DCs play a role in the immune response to the vaccine strain.",
keywords = "Adaptive immunity, Apoptosis, Dendritic cells, Glycoprotein D, HSV type 2, Migration, Unfolded protein response",
author = "Angello Retamal-D{\'i}az and Weiss, {Kayla A.} and Tognarelli, {Eduardo I.} and Mariela Freire and Bueno, {Susan M.} and Betsy Herold and Jacobs, {William R.} and Gonz{\'a}lez, {Pablo A.}",
year = "2017",
month = "11",
day = "10",
doi = "10.3389/fimmu.2017.01523",
language = "English (US)",
volume = "8",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "NOV",

}

TY - JOUR

T1 - US6 gene deletion in Herpes simplex virus type 2 enhances dendritic cell function and T cell activation

AU - Retamal-Díaz, Angello

AU - Weiss, Kayla A.

AU - Tognarelli, Eduardo I.

AU - Freire, Mariela

AU - Bueno, Susan M.

AU - Herold, Betsy

AU - Jacobs, William R.

AU - González, Pablo A.

PY - 2017/11/10

Y1 - 2017/11/10

N2 - Herpes simplex virus (HSV) type 1 (HSV-1) and type 2 (HSV-2) produce lifelong infections that are associated with frequent asymptomatic or clinically apparent reactivation. Importantly, HSV express multiple virulence factors that negatively modulate innate and adaptive immune components. Notably, HSV interfere with dendritic cell (DC) viability and function, likely hindering the capacity of the host to mount effective immunity against these viruses. Recently, an HSV-2 virus that was deleted in glycoprotein D was engineered (designated ΔgD-2). The virus is propagated on a complementing cell line that expresses HSV-1 gD, which permits a single round of viral replication. ΔgD-2 is safe, immunogenic, and provided complete protection against vaginal or skin challenges with HSV-1 and HSV-2 in murine models. Here, we sought to assess the interaction of ΔgD-2 with DCs and found that, in contrast to wild-type (WT) virus which induces DC apoptosis, ΔgD-2 promoted their migration and capacity to activate naïve CD8+ and CD4+ T cells in vitro and in vivo. Furthermore, DCs exposed to the WT and ΔgD-2 virus experienced different unfolded protein responses. Mice primed with DCs infected with ΔgD-2 in vitro displayed significantly reduced infection and pathology after genital challenge with virulent HSV-2 compared to non-primed mice, suggesting that DCs play a role in the immune response to the vaccine strain.

AB - Herpes simplex virus (HSV) type 1 (HSV-1) and type 2 (HSV-2) produce lifelong infections that are associated with frequent asymptomatic or clinically apparent reactivation. Importantly, HSV express multiple virulence factors that negatively modulate innate and adaptive immune components. Notably, HSV interfere with dendritic cell (DC) viability and function, likely hindering the capacity of the host to mount effective immunity against these viruses. Recently, an HSV-2 virus that was deleted in glycoprotein D was engineered (designated ΔgD-2). The virus is propagated on a complementing cell line that expresses HSV-1 gD, which permits a single round of viral replication. ΔgD-2 is safe, immunogenic, and provided complete protection against vaginal or skin challenges with HSV-1 and HSV-2 in murine models. Here, we sought to assess the interaction of ΔgD-2 with DCs and found that, in contrast to wild-type (WT) virus which induces DC apoptosis, ΔgD-2 promoted their migration and capacity to activate naïve CD8+ and CD4+ T cells in vitro and in vivo. Furthermore, DCs exposed to the WT and ΔgD-2 virus experienced different unfolded protein responses. Mice primed with DCs infected with ΔgD-2 in vitro displayed significantly reduced infection and pathology after genital challenge with virulent HSV-2 compared to non-primed mice, suggesting that DCs play a role in the immune response to the vaccine strain.

KW - Adaptive immunity

KW - Apoptosis

KW - Dendritic cells

KW - Glycoprotein D

KW - HSV type 2

KW - Migration

KW - Unfolded protein response

UR - http://www.scopus.com/inward/record.url?scp=85034059509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034059509&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2017.01523

DO - 10.3389/fimmu.2017.01523

M3 - Article

AN - SCOPUS:85034059509

VL - 8

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - NOV

M1 - 1523

ER -